Despite the advanced treatment for CRC, which comprises 5‐Fluorouracil, oxaliplatin, and EGFR, VEGFR inhibitors, the absolute burden of CRC has increased in India, with unsuccessful treatments and limitations of the existing therapy. This evidence concerns the gene EGFR and colorectal carcinoma.